Article

Highly potent novel multi-armoured IL13Rα2 CAR-T subverts the immunosuppressive…

medRxiv · 2025 · Mangolini, M.; Srivastava, S.; Souster, E.; Yang, Y.; Wang, H.; Karattil, R.; Schultz, L.; Ma, B.; Pombal, D.; Greenig, M.; Ramon, A.; Sormanni, P.; Cordoba, S.; Onuoha, S.

Key facts

Title Highly potent novel multi-armoured IL13Rα2 CAR-T subverts the immunosuppressive microenvironment of Glioblastoma
First author Mangolini, M.; Srivastava, S.; Souster, E.; Yang, Y.; Wang, H.; Karattil, R.; Schultz, L.; Ma, B.; Pombal, D.; Greenig, M.; Ramon, A.; Sormanni, P.; Cordoba, S.; Onuoha, S.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.01.10.632392
Devices mentioned BK110039, DEN000008, K022086
Product codes mentioned JCI, KIP, KIT, MVU, NDS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature